Jublia Revenue and Competitors
Estimated Revenue & Valuation
- Jublia's estimated annual revenue is currently $10.3M per year.
- Jublia's estimated revenue per employee is $184,500
Employee Data
- Jublia has 56 Employees.
- Jublia grew their employee count by 8% last year.
Jublia's People
| Name | Title | Email/Phone |
|---|
Jublia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.6M | 13 | 0% | N/A | N/A |
#2 | $25.4M | 124 | -2% | N/A | N/A |
#3 | $0.6M | 6 | N/A | N/A | N/A |
#4 | $0.7M | 7 | 40% | N/A | N/A |
#5 | $10.3M | 56 | 8% | N/A | N/A |
What Is Jublia?
Jublia is a global leader in business matching and event networking data analytics. Founded in 2013, Jublia has partnered leading B2B conferences, trade shows, corporate & associations event organizers in designing and executing the best business matching structure using Jublia's technology. This has allowed organizers to achieve high resultant meeting ROIs as well as in-depth customer insights. We differentiate ourselves as event networking specialists who work closely with every client, based on specific meeting needs and objectives of their events. With a track record of having the highest measurable networking performance in the industry, we provide the most meaningful business matching solution for exhibitions and conferences.
keywords:N/A
N/A
Total Funding
56
Number of Employees
$10.3M
Revenue (est)
8%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Jublia News
... on three drugs used to treat plaque psoriasis Bryhali, Siliq, and Duobrii and a fungal treatment called Jublia, the document stated.
Bausch Health faces a Department of Justice probe centered on the marketing and promotion of its drugs Bryhali, Siliq, Duobrii and Jublia.
Other Companies in Singapore
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $7.1M | 56 | 8% | N/A |
#2 | $7.1M | 56 | -8% | N/A |
#3 | $6.6M | 56 | 0% | N/A |
#4 | $6.6M | 56 | -28% | $27M |
#5 | $7.3M | 56 | 6% | N/A |